As of January 22, 2025, Instil Bio (TIL) has a market cap of $0.13 billion USD. According to our data, Instil Bio is ranked No.7507 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.13 B |
2.91%
|
Dec 31, 2024 | $0.12 B |
150.52%
|
Dec 29, 2023 | $49.73 M |
-39.52%
|
Dec 30, 2022 | $82.23 M |
-96.32%
|
Dec 31, 2021 | $2.23 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.14 B |
0.000 M
|
UK
|
bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
Cellectis
CLLS
|
$0.16 B |
4.659 M
|
France
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.11 B |
-0.000 M
|
USA
|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
Fate Therapeutics
FATE
|
$0.15 B |
0.000 M
|
USA
|
Allogene Therapeutics
ALLO
|
$0.40 B |
0.000 M
|
USA
|
Atara Biotherapeutics
ATRA
|
$39.63 M |
0.000 M
|
USA
|
Market Cap | = | TIL Stock Price | * | TIL Shares Outstanding |
= | $19.65 | * | 6.53 M | |
= | $0.13 B |